Document is current
Any future updates will be listed below
-
Authors
Elsaeed, Nourhan K.
Abdelmoety, Refaat H.
Elyamani, Ehab
Mahmoud, Lamiaa mohamed
Zidan, Mahmoud
Matter, Lamiaa Mohammed
Imam, Mohamed S.
Alosaimi, Fahad Mofareh
Alosaimi, Faisal Sultan
Almehery, Abdullah Abdulrahman
Asiri, Aryam Abdullah
Maadi, Refan A
Rabea, Hoda
Abdelrahman, Mona A.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct07313124 at ClinicalTrials.govDocuments that mention this clinical trial
Evaluation of relative safety and therapeutic efficacy of antihyperlipidemic drug regimens used alone or in combination in cardiovascular disease: randomized controlled study
https://doi.org/10.1186/s43094-026-01013-7
- License Information
-
More Information
Article History
Received: 24 May 2026
Accepted: 25 July 2026
First Online: 13 August 2026
Declarations
Ethics approval and consent to participate: All applicable ethical standards and institutional regulations were followed during the conduct of this study. This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of faculty of Medicine, Beni-Suef University (FMBSUREC/05012025/Elsaid).
Informed consent: Informed consent was obtained from all individual participants included in the study. Written informed consent was obtained from the parents.
Competing interests: The authors declare that there are no competing interests related to this work.
